Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “WT1 Expressing Carcinoma”

5 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 5 of 5 results

Early research (Phase 1)Active Not RecruitingNCT05103631
What this trial is testing

Interleukin-15 Armored Glypican 3-specific Chimeric Antigen Receptor Expressed in Autologous T Cells for Solid Tumors

Who this might be right for
Liver Cell CarcinomaSolid TumorWilms Tumor+5 more
Baylor College of Medicine 12
Testing effectiveness (Phase 2)Study completedNCT03761914
What this trial is testing

Galinpepimut-S in Combination With Pembrolizumab in Patients With Selected Advanced Cancers

Who this might be right for
Acute Myelogenous LeukemiaOvarian CancerColorectal Cancer+2 more
Sellas Life Sciences Group 26
Testing effectiveness (Phase 2)Ended earlyNCT02408016
What this trial is testing

Genetically Modified T Cells in Treating Patients With Stage III-IV Non-small Cell Lung Cancer or Mesothelioma

Who this might be right for
Advanced Pleural Malignant MesotheliomaHLA-A*0201 Positive Cells PresentRecurrent Non-Small Cell Lung Carcinoma+8 more
Fred Hutchinson Cancer Center 11
Early research (Phase 1)Looking for participantsNCT06198296
What this trial is testing

Immunotherapy For Adults With GPC3-Positive Solid Tumors Using IL-15 and IL-21 Armored GPC3-CAR T Cells

Who this might be right for
HepatoblastomaHepatocellular CarcinomaWilms Tumor+5 more
Baylor College of Medicine 21
Testing effectiveness (Phase 2)UnknownNCT00153608
What this trial is testing

WT1 Peptid Vaccination in Carcinomas

Who this might be right for
WT1 Expressing Carcinoma
Charite University, Berlin, Germany 25